Sage Therapeutics Announces First Quarter 2023 Financial Results and Highlights Pipeline and Business Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. AWK
10. ACN

Go back to Sage Therapeutics Announces First Quarter 2023 Financial Results and Highlights Pipeline and Business Progress

SAGE Therapeutics (SAGE) Tops Q1 EPS by 4c

May 2, 2023 6:34 AM EDT

SAGE Therapeutics (NASDAQ: SAGE) reported Q1 EPS of ($2.46), $0.04 better than the analyst estimate of ($2.50). Revenue for the quarter came in at $3.3 million versus the consensus estimate of $2.41 million.

For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.

... More